Table 8 Comparative Effects of Cost-sharing Elimination and Covariates on Utilization Among Women > = 50. (Odds Ratio, Confidence Interval (CI), P-value)
From: Effectiveness of Medicare cost-sharing elimination for Cancer screening on utilization
Comparator: A Biennial Pap Smear | ||||||
|---|---|---|---|---|---|---|
| Â | Annual Mammogram | Colonoscopy | ||||
| Â | Odds Ratio | 95% CI | P-value | Odds Ratio | 95% CI | P-value |
Transition: 2011–2012 | 1.12 | 0.78–1.60 | 0.54 | 1.17 | 0.75–1.84 | 0.49 |
Post-policy: 2013 | 1.51 | 0.88–2.59 | 0.14 | 1.29 | 0.55–3.01 | 0.55 |
N | 12,377 | 12,377 | ||||